Altana AG

ots Ad hoc-Service: Altana AG ALTANA raises the forecast for the market sales of its gastrointestinal medication Pantoprazole:

Ad hoc-announcement edited and sent by DGAP. The sender is solely responsible for the contents of this announcement. ----------------------------------------------------- Bad Homburg v. d. Höhe Hessen (ots Ad hoc-Service) - ALTANA raises the forecast for the market sales of its gastrointestinal medication Pantoprazole: For the year 2001 the company now expects world-wide sales in the blockbuster of around EUR 1.1 billion (originally: EUR 900 million), and for the year 2002 roughly EUR 1.3 to 1.4 billion (originally: EUR 1,200 million). On March 26, 2001 Aventis Pharmaceuticals (the US pharmaceutical company of Aventis S.A.) and Byk Gulden have signed an agreement to jointly develop and promote Byk Guldens new inhaled corticosteroid, Ciclesonide, for the treatment of asthma. With this agreement, ALTANA takes its US strategy one step further. From todays perspective, a sales increase of around 20 percent emerges for the first quarter 2001. The rise in profit will significantly surpass this rate as far as can be judged today. For the whole year 2001 ALTANA expects a sales increase of some 15 percent and again a disproportionately high profit increase. End of message ----------------------------------------------------- Internet: http://recherche.newsaktuell.de Original-Content von: Altana AG, übermittelt durch news aktuell

Themen in dieser Meldung


Das könnte Sie auch interessieren: